<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03510013</url>
  </required_header>
  <id_info>
    <org_study_id>HE601228</org_study_id>
    <nct_id>NCT03510013</nct_id>
  </id_info>
  <brief_title>1-1-8 Wash-in for Sevoflurane Low Flow Anesthesia</brief_title>
  <official_title>1-1-8 Wash-in for Sevoflurane Low Flow Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Khon Kaen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a new wash-in technique for sevoflurane low flow anesthesia with
      fresh gas flow of O2:N2O or O2:air 1:1 L/min with sevoflurane 8%.

      The objective of this study is to identify time to achieve alveolar concentration of
      sevoflurane at 1, 1.5, 2, 2.5, 3, and 3.5%
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The benefits of low flow anesthesia are economic, less pollution, more heat and humidity
      preservation but it requires appropriate wash-in phase. The current wash-in protocols for
      sevoflurane are complicated and time consuming. The investigators propose a new 1-1-8
      sevoflurane wash-in protocol which is more simple and predictable.

      The objective of this study is to identify time to achieve alveolar concentration of
      sevoflurane at 1, 1.5, 2, 2.5, 3, and 3.5% with 1-1-8 wash-in protocol.

      All patients will receive iv propofol 2 mg/kg as induction agent and succinyl choline 1.5
      mg/kg for intubation. Then the ventilation will be controlled to achieve end-tidal CO2 30-35
      mmHg with O2:N2O or O2:air 1:1 L/min with sevoflurane 8%. Time to achieve alveolar
      concentration of sevoflurane at 1, 1.5, 2, 2.5, 3, and 3.5% will be recorded and analyzed.
      After that, the concentration of sevoflurane and anesthetic technique will be adjusted to
      requirement of anesthesiologist.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All participants will receive sevoflurane 8% with O2:N2O or O2:air 1:1 L/min under controlled ventilation. Time to achieve alveolar concentration of sevoflurane of 1%, 1.5%, 2%, 2.5%, 3% and 3.5% will be recorded.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time</measure>
    <time_frame>participants will be followed until alveolar concentration of sevoflurane reaches 3.5%, as expected of 10 minutes</time_frame>
    <description>Time (in second) to achieve alveolar concentration of sevoflurane 1, 1.5, 2, 2.5, 3, and 3.5%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>participants will be followed until alveolar concentration of sevoflurane reaches 3.5%, as expected of 10 minutes]</time_frame>
    <description>Heart rate (beat/min) at alveolar concentration of sevoflurane of 1, 1.5, 2, 2.5, 3 and 3.5%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>participants will be followed until alveolar concentration of sevoflurane reaches 3.5%, as expected of 10 minutes]</time_frame>
    <description>Blood pressure (systolic and diastolic (mmHg)) at alveolar concentration of sevoflurane of 1, 1.5, 2, 2.5, 3 and 3.5%</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>1-1-8 wash-in</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wash-in using O2:N2O or O2:air 1:1 L/min with sevoflurane 8%</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>1-1-8 wash-in</intervention_name>
    <description>wash-in phase during start of low flow anesthesia</description>
    <arm_group_label>1-1-8 wash-in</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Drug used for wash-in protocol</description>
    <arm_group_label>1-1-8 wash-in</arm_group_label>
    <other_name>Inhalation anesthetic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA classification I-II

          -  age 18-65 years

        Exclusion Criteria:

          -  BMI &gt; 35

          -  contraindicated for N2O

          -  â€¢ with pulmonary or cardiac disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thepakorn Sathitkarnmanee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Khon Kaen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thepakorn Sathitkarnmanee, MD</last_name>
    <phone>66819547622</phone>
    <email>thepakorns@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine, Khon Kaen University</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thepakorn Sathitkarnmanee, MD</last_name>
      <phone>+66819547622</phone>
      <email>thepakorns@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>April 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2018</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Thepakorn Sathitkarnmanee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>low flow anesthesia</keyword>
  <keyword>wash-in</keyword>
  <keyword>sevoflurane</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Anesthetics, Inhalation</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

